EpiVax
Latest round
- Seed
Last raised
- Jun 1998
Total raised
- Undisclosed
Investors
- 1
About EpiVax
-based biotechnology and bioanalytical contract research organization (CRO) specializing in immunogenicity risk assessment for biologic drugs and vaccines. Founded in 1998, the company supports pharmaceutical and biotechnology developers by identifying and mitigating immune-related risks early in drug development through proprietary immunoinformatics software platforms and in vitro laboratory services.
Who invested in EpiVax
1 investor across 1 round
See all investors in EpiVax
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Jun 1, 1998
Amount
Undisclosed
Investors
Questions about EpiVax
Who invested in EpiVax?
EpiVax has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has EpiVax raised?
EpiVax has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did EpiVax last raise money?
EpiVax's most recent round on record is a Seed, in Jun 1998.
What does EpiVax do?
-based biotechnology and bioanalytical contract research organization (CRO) specializing in immunogenicity risk assessment for biologic drugs and vaccines.
Where is EpiVax headquartered?
EpiVax is headquartered in Providence, US.
Which VCs invest in companies like EpiVax?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at EpiVax's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Seed
Raising like EpiVax? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.